NCT02985450View on ClinicalTrials.gov

A Prospective Study of HBV Immunity and HBV Vaccination in Patients With NAFLD in Canada

CompletedOBSERVATIONAL

Enrollment

82

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

January 31, 2021

Study Completion Date

January 31, 2021

Conditions

Non-Alcoholic Fatty Liver DiseaseHepatitis BVaccine Reaction

Interventions

BIOLOGICAL

Engerix-B

Hepatitis B Vaccine

Trial Locations (1)

T2N 4Z6

University of Calgary, Calgary

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

collaborator

GlaxoSmithKline

INDUSTRY

lead

University of Calgary

OTHER